Superluminal Medicines secures $120m to fast-track GPCR drug discovery
Longevity Technology - 12-Sep-2024Innovative platform accelerates drug discovery for metabolic diseases and more
Join the club for FREE to access the whole archive and other member benefits.
Generative biology and chemistry company
Superluminal Medicines is a generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. The company’s platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure.
Visit website: https://www.superluminalrx.com/
Details last updated 28-Sep-2024
Innovative platform accelerates drug discovery for metabolic diseases and more